Claret Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3M Sell
58,479
-761
-1% -$177K 1.71% 18
2025
Q4
$12.3M Sell
59,240
-615
-1% -$122K 1.42% 19
2025
Q3
$11.1M Sell
59,855
-1,271
-2% -$218K 1.32% 20
2025
Q2
$9.34M Sell
61,126
-364
-0.6% -$56K 1.21% 21
2025
Q1
$10.2M Sell
61,490
-1,202
-2% -$188K 1.47% 17
2024
Q4
$9.07M Sell
62,692
-301
-0.5% -$46.6K 1.43% 19
2024
Q3
$10.2M Hold
62,993
1.67% 15
2024
Q2
$9.21M Sell
62,993
-498
-0.8% -$74.1K 1.64% 15
2024
Q1
$10M Buy
63,491
+281
+0.4% +$44.7K 1.69% 15
2023
Q4
$9.91M Sell
63,210
-33
-0.1% -$5.06K 1.77% 15
2023
Q3
$9.85M Sell
63,243
-136
-0.2% -$22.4K 1.93% 15
2023
Q2
$10.5M Sell
63,379
-974
-2% -$157K 2.05% 16
2023
Q1
$9.97M Sell
64,353
-302
-0.5% -$48.8K 1.97% 17
2022
Q4
$11.4M Sell
64,655
-152
-0.2% -$26.2K 2.52% 14
2022
Q3
$10.6M Sell
64,807
-633
-1% -$107K 2.51% 16
2022
Q2
$11.6M Sell
65,440
-528
-0.8% -$94.1K 2.51% 17
2022
Q1
$11.7M Buy
65,968
+211
+0.3% +$35.9K 2.25% 18
2021
Q4
$11.2M Sell
65,757
-572
-0.9% -$93.6K 2.08% 17
2021
Q3
$10.7M Sell
66,329
-847
-1% -$145K 1.84% 19
2021
Q2
$11.1M Sell
67,176
-655
-1% -$108K 1.81% 20
2021
Q1
$11.1M Sell
67,831
-527
-0.8% -$85.3K 2.07% 18
2020
Q4
$10.8M Sell
68,358
-1,005
-1% -$148K 2.12% 17
2020
Q3
$10.3M Sell
69,363
-485
-0.7% -$71.8K 2.3% 14
2020
Q2
$9.82M Sell
69,848
-1,678
-2% -$245K 2.33% 13
2020
Q1
$9.38M Sell
71,526
-3,405
-5% -$483K 2.65% 12
2019
Q4
$10.9M Sell
74,931
-222
-0.3% -$30.1K 2.1% 13
2019
Q3
$9.72M Sell
75,153
-1,891
-2% -$249K 2% 12
2019
Q2
$10.7M Sell
77,044
-1,135
-1% -$157K 2.22% 9
2019
Q1
$10.9M Sell
78,179
-380
-0.5% -$50.9K 2.17% 11
2018
Q4
$10.1M Sell
78,559
-2,625
-3% -$366K 2.25% 10
2018
Q3
$11.2M Buy
81,184
+771
+1% +$102K 2.16% 11
2018
Q2
$9.76M Buy
80,413
+2,123
+3% +$265K 1.99% 13
2018
Q1
$10M Sell
78,290
-783
-1% -$106K 2.28% 11
2017
Q4
$11M Buy
+79,073
New +$11M 2.41% 10

Other funds holding JNJ

Claret Asset Management's JNJ Position: Q1 2026 in Review

Claret Asset Management reduced its Johnson & Johnson (JNJ) stake by 1.3% in Q1 2026, selling an estimated $177K and leaving 58,479 shares worth $14.3M. The position accounts for 1.71% of the portfolio, ranked #18.

Claret Asset Management first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Claret Asset Management held 58,479 shares of Johnson & Johnson worth $14.3M as of Q1 2026.
  • Claret Asset Management sold 761 Johnson & Johnson shares in Q1 2026, an estimated $177K.
  • Johnson & Johnson made up 1.71% of Claret Asset Management's portfolio in Q1 2026, its #18 holding.
  • Claret Asset Management first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Claret Asset Management's 13F filing for Q1 2026, filed 11 May 2026.